GFM
NVCR icon

GF Fund Management’s NovoCure NVCR Stock Holding History

GF Fund Management’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36.5K Sell
2,409
-92
-4% -$1.39K ﹤0.01% 431
2026
Q1 		$27.3K Buy
2,501
+302
+14% +$3.77K ﹤0.01% 466
2025
Q4 		$28.4K Sell
2,199
-206
-9% -$2.64K ﹤0.01% 469
2025
Q3 		$31.1K Sell
2,405
-365
-13% -$4.88K ﹤0.01% 440
2025
Q2 		$49.3K Hold
2,770
– – ﹤0.01% 416
2025
Q1 		$49.4K Buy
2,770
+498
+22% +$11.3K ﹤0.01% 422
2024
Q4 		$67.7K Buy
+2,272
New +$48.1K ﹤0.01% 362

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

GF Fund Management's NVCR Position: Q2 2026 in Review

GF Fund Management reduced its NovoCure (NVCR) stake by 3.7% in Q2 2026, selling an estimated $1.39K and leaving 2,409 shares worth $36.5K. The position accounts for ﹤0.01% of the portfolio, ranked #431.

GF Fund Management first reported a position in NVCR in Q4 2024 and has held it in 7 quarters since. The position peaked at $67.7K in Q4 2024. 218 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.

  • GF Fund Management held 2,409 shares of NovoCure worth $36.5K as of Q2 2026.
  • GF Fund Management sold 92 NovoCure shares in Q2 2026, an estimated $1.39K.
  • NovoCure made up ﹤0.01% of GF Fund Management's portfolio in Q2 2026, its #431 holding.
  • GF Fund Management first reported a position in NovoCure in Q4 2024 and has held it in 7 quarters since.
  • GF Fund Management's NovoCure position peaked at $67.7K in Q4 2024.
  • 218 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.